AbbVie (ABBV)Officer sold ~$310K

~$310K

Approx. value · 1,800 sh @ $172.24

6,983

Holds after · shares reported

Traded

Dec 16, 2024

Filed

Dec 18, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Oct 18, 2024FDAFDA drug approval: Botox Cosmetic
2. Nov 20, 2024CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
3. Dec 6, 2024CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
4. Dec 16, 2024 · this disclosureInsiderOfficer sold ~$310K of ABBV shares in the open market

What came next

1. Jan 15, 2025Congress · 1 personMembers of Congress: 2 purchases
2. Feb 7, 2025FDAFDA drug approval: Emblaveo
3. Feb 20, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
4. Feb 24, 2025CongressDisclosed purchase of ABBV — reported range $50,001 - $100,000
5. Feb 25, 2025CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
6. Feb 26, 2025Insider · 2 peopleInsiders: 8 sales (~$9.9M)
7. Feb 28, 2025Insider · 2 peopleInsiders: 4 sales (~$21.0M)
8. Mar 3, 2025Insider · 3 peopleInsiders: 5 sales (~$9.6M)
9. Mar 14, 2025InsiderCFO sold ~$3.75M of ABBV shares in the open market
10. Mar 17, 2025CongressDisclosed purchase of ABBV — reported range $1,001 - $15,000
11. Mar 31, 2025Insider · 1 personInsiders: 2 sales (~$12.4M)

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for AbbVie

For AbbVie, OQRO holds 2 insider filings (SEC Form 4 or Form 144), 2 Congress trade reports, 130 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ABBV page.

Other recent filings by Kevin K Buckbee, SVP, CONTROLLER

• SEC Form 4 at AbbVie (ABBV)Feb 28, 2025
• SEC Form 4 at AbbVie (ABBV)Feb 28, 2025

The full history of Kevin K Buckbee, SVP, CONTROLLER is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at AbbVie

• House Clerk periodic transaction reportSep 18, 2026
• SEC Form 13F-HRAug 26, 2026
• SEC Form 13F-HRAug 25, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 13F-HRAug 17, 2026
• SEC Form 144Aug 14, 2026

Everything OQRO holds on this company is on its ABBV page.